Global CGM Market will be US$ 5.6 Billion by 2025 | Renub Research

Continuous Glucose Monitor have significant advantages over other monitoring devices, especially for Type1 diabetes patients. It gives details for blood glucose continuously as compared to the traditional glucose monitor, which offers one time result
By: Renub Research
 
 
Spread the Word
Listed Under

Tag:
* Global CGM Market

Industry:
* Business

Location:
* Roswell - Georgia - US

ROSWELL, Ga. - July 22, 2020 - PRLog -- According to the latest report by Renub Research, titled "Continuous Glucose Monitoring (CGM) Market, Users, Reimbursement Policy, Global Analysis, CGM Components Market, Diabetes (Type1 & 2) Population, & Forecast" Medical science is undergoing massive development from the past few years. There has been tremendous research and development in blood glucose monitoring devices due to this Continuous Glucose Monitoring (CGM) is the result of this invention. CGM is one of the recent developments in the field of diabetes management. It monitors blood glucose through subcutaneous by inserting a biosensor or by transcutaneous. This embedded sensor monitors the glucose level in blood or interstitial fluid and then transmits data to the receiver/monitor using a transmitter, which become helpful in the treatment of diabetics. According to Renub Research report, the Global CGM Market is anticipated to be US$ 5.6 Billion by the end of the year 2025.

Due to all these several benefits of Continuous Glucose Monitor over other monitoring devices, this has become a vital device for management of diabetes, especially for Type1 diabetes patients. It gives details for blood glucose continuously as compared to the traditional glucose monitor, which offers one time result. Multiple medical device companies are investing heavily in the development of producing technologically advanced Contiguous Blood Glucose Monitor System to have a competitive advantage over other healthcare companies.

COVID-19 impact on Continuous Glucose Monitoring Systems

COVID-19 has affected global healthcare system, and diabetes management is one of them. Currently, healthcare facilities are focusing on the treatment of COVID-19 patients, and other patients are not receiving medical facilities as they were receiving in the past. Most of the health experts are providing consultation through telehealth systems.

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow the Link for Report Costomization: https://www.renub.com/global-cgm-market-users-reimburseme...

Contact
Renub Research
info@renub.com
+1 678-302-0700
End
Email:***@renub.com
Tags:Global CGM Market
Industry:Business
Location:Roswell - Georgia - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Renub Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share